what's trending

5 most popular innovation stories in Houston this week

Where to be at SXSW this year was among this week's top stories on InnovationMap. Photo via SXSW.com

Editor's note:Another week has come and gone, and it's time to round up the top headlines from the past few days. Trending Houston tech and startup news on InnovationMap included innovators to know, events not to miss at SXSW, an industrial robotics company raising funding, and more.


3 Houston innovators to know this week

This week's roundup of Houston innovators includes Sujatha Kumar of Dsider, Andrew Bruce of Data Gumbo, and Payal Patel of Softeq. Courtesy photos

In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from software to blockchain — recently making headlines in Houston innovation. Click here to continue reading.

Houston innovators: Here's what not to miss at SXSW

Here's everything you should attend at SXSW this year. Photo courtesy of SXSW

Headed to SXSW this year and hoping to make meaningful Houston tech and innovation connections and hear from thought leaders? Look no further than these key events and panels.

From meetups to fireside chats, here's everything you need to know about tapping into the Houston innovation ecosystem by way of the Austin festival. Click here to continue reading.

Industrial robotics company raises $73M series C, prepares to grow Houston office

Gecko Robotics has over 50 Houston area employees working on robotics and software solutions for infrastructure. Photo via GeckoRobotics.com

A Pittsburgh-based tech company that has created a hardware and software solution for industrial asset management has closed its latest round of funding.

Gecko Robotics, which has a growing Houston office, has closed its series C funding round at $73 million. The round was led by XN with participation from Founders Fund, XYZ, Drive Capital, Snowpoint Ventures, Joe Lonsdale, Mark Cuban, Gokul Rajaram, and others.

Gecko's Houston office was stood up in 2019 as a way to further grow oil and gas industry customers. Gecko has over 100 customers within infrastructure, power, energy, and more, Troy Demmer, chief product officer and co-founder, tells InnovationMap. Gecko's customers include Dow Chemical, Marathon, Shell, and Chevron, to name a few. Click here to continue reading.

Overheard: Houston experts discuss women in med tech, insight from investors, and more

Health care innovators joined Houston Methodist and Texas A&M University's ENMED program to discuss women in health care innovation and venture capital investment. Photo courtesy of Houston Methodist

Houston's health innovation community is making strides every day toward greater quality of care and technology adoption — but what challenges is the industry facing these days?

Through a partnership between Houston Methodist and Texas A&M University's ENMED program at Houston Tech Rodeo, health innovators weighed in on topics surrounding the industry, including biases and investment opportunities. Click here to continue reading.

Electric buses are on track to roll into Houston

METRO is moving toward the purchase of only zero-emission buses by 2030. Image courtesy of NovaBus

Within the next year or so, you’ll see electric-powered buses buzzing around Bayou City.

The Metropolitan Transit Authority of Harris County (METRO) recently awarded a $22 million contract to Saint-Eustache, Canada-based Nova Bus for the production of 20 battery-powered electric buses. The contract includes an option for another 20 buses.

The first 20 buses, to be manufactured at the Nova Bus factory in Plattsburgh, New York, are expected to be on local roads sometime in in late 2022 or early 2023. They’ll run on the 402 Bellaire Express (Quickline) and 28 OST-Wayside routes.

METRO also plans to test three to five electric buses powered by hydrogen fuel cells. Furthermore, METRO is a member of the Automated Bus Consortium, a national organization of transportation agencies working toward development of a full-size, electric-powered automated bus. Click here to continue reading.

Trending News

Building Houston

 
 

Houston-based Melax Tech has developed multiple Natural language processing tools that are used by more than 650 health care and life science organizations. Photo via MelaxTech.com

Melax Tech Partners, a leader in natural language technology processing, announced a new partnership with the University of California at Irvine that will help researchers derive insights from the UCI Health Data Science Platform’s electronic health records system and improve patient care.

Melax will implement its signature text annotation tool LANN to pull information from clinical notes, and its CLAMP product to develop natural language processing customizations through the use of AI, according to a statement from the company.

“There has been a strong desire among UCI researchers to have the capability to analyze free-text clinical narrative data using cutting-edge NLP technologies," Kai Zheng, chief research information officer at UCI Health Affairs, says in a statement. "We are delighted to have this opportunity to work with Melax Tech to deploy their AI-driven annotation and analytics tools to help our researchers advance their research agenda by leveraging the vast amount of free-text data that our health system has accumulated in the past two decades.”

Natural language processing, or NLP, allows organizations and healthcare groups to sift through and analyze massive amounts of data at a rapid rate through the use of machine learning and AI. Houston-based Melax Tech, founded in 2017, has developed multiple NLP tools that are used by more than 650 health care and life science organizations, according to its website.

In addition to the recent partnership with UC Irvine, Melax has also recently partnered with Vanderbilt University Medical Center and the University of Western Pennsylvania on similar clinical projects.

Melax has also used its platforms to pull vital information from datasets relating to COVID-19, in both medical and social settings.

In March 2022, it was awarded a Phase 1 NIH Award, valued at $300,000, to develop informatics tools based on COVID-19 datasets with the San Diego Supercomputer Center at UC San Diego. The tool aims to help researchers better understand vast amounts of virus-related data and connect findings with other similar results.

In August, Melax also received another $300,000 grant from the National Institute of Allergy and Infectious Diseases to develop NLP-based algorithms that will "model, extract and synthesize vaccine misinformation from multiple popular social media sources," according to a statement. Melax will also develop a visualization that presents its findings on the misinformation into a compressible format.

"This is a very real topic affecting culture at present," Andre Pontin, CEO at Melax Tech, says in a statement. "And shows that we as a collective business and group of experts continue to be on the cutting-edge of science in the NLP and AI domain."

Trending News